MARKER THERAPEUTICS INC's ticker is MRKR and the CUSIP is 57055L107. A total of 75 filers reported holding MARKER THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $45,000 | +45.2% | 19,972 | -8.5% | 0.00% | – |
| Q4 2020 | $31,000 | +6.9% | 21,820 | +14.4% | 0.00% | – |
| Q3 2020 | $29,000 | -14.7% | 19,070 | +16.0% | 0.00% | – |
| Q2 2020 | $34,000 | -38.2% | 16,446 | -43.1% | 0.00% | – |
| Q1 2020 | $55,000 | -49.5% | 28,908 | -24.8% | 0.00% | – |
| Q4 2019 | $109,000 | +179.5% | 38,439 | +381.2% | 0.00% | – |
| Q3 2019 | $39,000 | -77.1% | 7,988 | -63.1% | 0.00% | – |
| Q2 2019 | $170,000 | – | 21,668 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AR ASSET MANAGEMENT INC | 70,700 | $321 | 0.09% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |